By targeting phosphodiesterase 4B (PDE4B) and cyclin-dependent kinase 8 (CDK8), this miRNA modulates activity by reducing its phosphorylation and nuclear migration, impeding the progression of GC. This evidence concerns the gene PDE4B and gastric cancer.